{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:31:36Z","timestamp":1787016696557,"version":"build-2736575974"},"reference-count":103,"publisher":"American Society for Microbiology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Two cholera vaccines, sold as Shanchol and Dukoral, are currently available. This review presents a critical analysis of the protective efficacies of these vaccines. Children under 5 years of age are very vulnerable to cholera and account for the highest incidence of cholera cases and more than half of the resulting deaths. Both Shanchol and Dukoral are two-spaced-dose oral vaccines comprising large numbers of killed cholera bacteria. The former contains\n                    <jats:named-content content-type=\"genus-species\">Vibrio cholerae<\/jats:named-content>\n                    O1 and O139 cells, and the latter contains\n                    <jats:named-content content-type=\"genus-species\">V. cholerae<\/jats:named-content>\n                    O1 cells with the recombinant B subunit of cholera toxin. In a field trial in Kolkata (India), Shanchol, the preferred vaccine, protected 45% of the test subjects in all of the age groups and only 17% of the children under 5 years of age during the first year of surveillance. In a field trial in Peru, two spaced doses of Dukoral offered negative protection in children under 5 years of age and little protection (15%) in vaccinees over 6 years of age during the first year of surveillance. Little is known about Dukoral's long-term protective efficacy. Both of these vaccines have questionable compositions, using\n                    <jats:named-content content-type=\"genus-species\">V. cholerae<\/jats:named-content>\n                    O1 strains isolated in 1947 that have been inactivated by heat and formalin treatments that may denature protein. Immunological studies revealed Dukoral's reduced and short-lived efficacy, as measured by several immunological endpoints. Various factors, such as the necessity for multiple doses, poor protection of children under 5 years of age, the requirement of a cold supply chain, production costs, and complex logistics of vaccine delivery, greatly reduce the suitability of either of these vaccines for endemic or epidemic cholera control in resource-poor settings.\n                  <\/jats:p>","DOI":"10.1128\/cvi.00378-14","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T20:30:43Z","timestamp":1406147443000},"page":"1195-1205","source":"Crossref","is-referenced-by-count":36,"title":["Critical Analysis of Compositions and Protective Efficacies of Oral Killed Cholera Vaccines"],"prefix":"10.1128","volume":"21","author":[{"given":"Shahjahan","family":"Kabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"key20180919073742_B1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJMp1214179","article-title":"The cure for cholera\u2014improving access to safe water and sanitation","volume":"368","author":"Waldman","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"key20180919073742_B2","first-page":"2","volume-title":"Cholera and other Vibrio illness surveillance (COVIS) overview","author":"Centers for Disease Control and Prevention","year":"2012"},{"key":"key20180919073742_B3","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/IAI.62.9.3859-3863.1994","article-title":"Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 E1 Tor cholera strains","volume":"62","author":"Hall","year":"1994","journal-title":"Infect. Immun."},{"key":"key20180919073742_B4","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/IAI.62.5.2108-2110.1994","article-title":"Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences","volume":"62","author":"Johnson","year":"1994","journal-title":"Infect. Immun."},{"key":"key20180919073742_B5","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1128\/AEM.00066-06","article-title":"Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh","volume":"72","author":"Alam","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"key20180919073742_B6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0140-6736(93)90480-5","article-title":"Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India","volume":"341","author":"Ramamurthy","year":"1993","journal-title":"Lancet"},{"key":"key20180919073742_B7","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1128\/IAI.72.8.4448-4454.2004","article-title":"The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139","volume":"72","author":"Asaduzzaman","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073742_B8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral vaccine with and without the B subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect. Immun."},{"key":"key20180919073742_B9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.39.1.452-455.1983","article-title":"Immmunochemical properties of the major outer membrane protein of Vibrio cholerae","volume":"39","author":"Kabir","year":"1983","journal-title":"Infect. Immun."},{"key":"key20180919073742_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.32.1.1-8.1981","article-title":"Antibacterial and antitoxin responses in the serum and milk of cholera patients","volume":"32","author":"Majumdar","year":"1981","journal-title":"Infect. Immun."},{"key":"key20180919073742_B11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/IAI.57.2.495-501.1989","article-title":"Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens","volume":"57","author":"Richardson","year":"1989","journal-title":"Infect. Immun."},{"key":"key20180919073742_B12","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1128\/IAI.01101-08","article-title":"Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation","volume":"77","author":"Bhuiyan","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073742_B13","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1128\/IAI.00369-09","article-title":"Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh","volume":"77","author":"Harris","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073742_B14","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1128\/IAI.00793-09","article-title":"Memory T-cell responses to Vibrio cholerae O1 infection","volume":"77","author":"Weil","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073742_B15","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1128\/IAI.71.8.4808-4814.2003","article-title":"Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers","volume":"71","author":"Qadri","year":"2003","journal-title":"Infect. Immun."},{"key":"key20180919073742_B16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B17","first-page":"552","article-title":"Protective immunity against Vibrio cholerae infection in the rabbit","volume":"266","author":"Guin\u00e9e","year":"1987","journal-title":"Zentralbl. Bakteriol. Mikrobiol. Hyg. A"},{"key":"key20180919073742_B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1099\/00222615-24-1-29","article-title":"Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation","volume":"24","author":"Kabir","year":"1987","journal-title":"J. Med. Microbiol."},{"key":"key20180919073742_B19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/143.6.818","article-title":"Duration of infection-derived immunity to cholera","volume":"143","author":"Levine","year":"1981","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B20","first-page":"743","article-title":"Der zweite Bericht der deutschen Cholera-Commission","volume":"9","author":"Koch","year":"1883","journal-title":"Dtsch. Med. Wochenschr."},{"key":"key20180919073742_B21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jhmas\/XXXVII.4.399","article-title":"Waldemar Haffkine's cholera vaccines and the Ferran-Haffkine priority dispute","volume":"37","author":"Bornside","year":"1982","journal-title":"J. Hist. Med. Allied Sci."},{"key":"key20180919073742_B22","first-page":"18","article-title":"Efficacy of cholera vaccines","volume-title":"The immunological basis for immunization series\u2014module 14: cholera","author":"Bhadra","year":"2010"},{"key":"key20180919073742_B23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"key20180919073742_B24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"ii","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"key20180919073742_B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"key20180919073742_B27","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"key20180919073742_B28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"key20180919073742_B29","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"key20180919073742_B30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1086\/315462","article-title":"Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru","volume":"181","author":"Taylor","year":"2000","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B31","volume-title":"Oral cholera vaccine stockpile for emergency response","author":"World Health Organization","year":"2005"},{"key":"key20180919073742_B32","volume-title":"Shanchol, inactivated oral cholera vaccine","author":"World Health Organization","year":"2011"},{"key":"key20180919073742_B33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4269\/ajtmh.13-0183","article-title":"Use of oral cholera vaccine in Haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073742_B34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4269\/ajtmh.13-0171","article-title":"Cholera vaccination in urban Haiti","volume":"89","author":"Rouzier","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073742_B35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4269\/ajtmh.13-0200","article-title":"Development of a cholera vaccination policy on the island of Hispaniola, 2010-2013","volume":"89","author":"Vicari","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073742_B36","first-page":"6","volume-title":"Cholera toolkit","year":"2013"},{"key":"key20180919073742_B37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"key20180919073742_B38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1204927","article-title":"Cholera surveillance during the Haiti epidemic\u2014the first 2 years","volume":"368","author":"Barzilay","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"key20180919073742_B39","volume-title":"WHO Epidemiological update cholera 20 March 2014","author":"Pan American Health Organization","year":"2014"},{"key":"key20180919073742_B40","first-page":"63","article-title":"XXI Meeting of the Technical Advisory Group on Vaccine-Preventable Diseases: Vaccination: A Shared Responsibility","volume-title":"3 to 5 July 2013, Quito, Ecuador","year":"2013"},{"key":"key20180919073742_B41","first-page":"17","volume-title":"A randomized controlled trial of the bivalent killed whole cell oral cholera vaccine in eastern Kolkata, West Bengal, India. Protocol version 3.0, section 6.1, study agents (vaccine and placebo)","year":"2008"},{"key":"key20180919073742_B42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbadis.2003.08.004","article-title":"Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization","volume":"1639","author":"Chatterjee","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"key20180919073742_B43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/mpat.1994.1024","article-title":"Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence","volume":"16","author":"Weintraub","year":"1994","journal-title":"Microb. Pathog."},{"key":"key20180919073742_B44","first-page":"361","article-title":"Antigenic analysis of Vibrio cholerae O1 by crossed immunoelectrophoresis","volume":"270","author":"Kabir","year":"1989","journal-title":"Zentralbl. Bakteriol. Mikrobiol. Hyg. A"},{"key":"key20180919073742_B45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7883\/yoken.JJID.2000.181","article-title":"Current status of cholera and rise of novel mucosal vaccine","volume":"53","author":"Yamamoto","year":"2000","journal-title":"Jpn. J. Infect. Dis."},{"key":"key20180919073742_B46","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1128\/IAI.62.5.1830-1834.1994","article-title":"Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing","volume":"62","author":"di Tommaso","year":"1994","journal-title":"Infect. Immun."},{"key":"key20180919073742_B47","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1074\/jbc.M310752200","article-title":"Identification of formaldehyde-induced modifications in proteins: reactions with model peptides","volume":"279","author":"Metz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"key20180919073742_B48","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1128\/JCM.00432-11","article-title":"Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe","volume":"49","author":"Islam","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"key20180919073742_B49","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS One"},{"key":"key20180919073742_B50","first-page":"8","volume-title":"Zimbabwe cholera control guides","year":"2009","edition":"3rd edition"},{"key":"key20180919073742_B51","first-page":"3","article-title":"WHO Expert Committee on Cholera. Second report","volume":"352","year":"1967","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"key20180919073742_B52","first-page":"257","article-title":"Microbial toxins and diarrhoeal diseases","volume":"112","author":"Finkelstein","year":"1985","journal-title":"Ciba Found. Symp."},{"key":"key20180919073742_B53","first-page":"381","article-title":"Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh\u2014three years of observation","volume":"49","author":"Mosley","year":"1973","journal-title":"Bull. World Health Organ."},{"key":"key20180919073742_B54","first-page":"741","article-title":"A controlled field trial of an aluminium phosphate-adsorbed cholera vaccine in Calcutta","volume":"58","author":"Pal","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"key20180919073742_B55","first-page":"619","article-title":"A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973-75","volume":"56","author":"Saroso","year":"1978","journal-title":"Bull. World Health Organ."},{"key":"key20180919073742_B56","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/IAI.13.3.735-740.1976","article-title":"Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin\/toxoid","volume":"13","author":"Svennerholm","year":"1976","journal-title":"Infect. Immun."},{"key":"key20180919073742_B57","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up","volume":"14","author":"van Loon","year":"1996","journal-title":"Vaccine"},{"key":"key20180919073742_B58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/infdis\/164.2.407","article-title":"Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh","volume":"164","author":"Sack","year":"1991","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1073\/pnas.86.2.481","article-title":"Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development","volume":"86","author":"Sanchez","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073742_B60","volume-title":"Dukoral monograph","year":"2007"},{"key":"key20180919073742_B61","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"key20180919073742_B62","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1086\/319682","article-title":"Reply to misleading negative findings in a field trial of killed, oral cholera vaccine in Peru","volume":"183","author":"Taylor","year":"2001","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B63","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1086\/319673","article-title":"Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru","volume":"183","author":"Clemens","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"3","key":"key20180919073742_B64","doi-asserted-by":"publisher","first-page":"CD008603","DOI":"10.1002\/14651858.CD008603.pub2","article-title":"Oral vaccines for preventing cholera","volume":"16","author":"Sinclair","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"key20180919073742_B65","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"key20180919073742_B66","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B67","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"key20180919073742_B68","first-page":"1633","article-title":"Why do we not yet have a suitable vaccine against cholera?","volume":"371B","author":"Finkelstein","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"key20180919073742_B69","volume-title":"Dukoral product information","year":"2014"},{"key":"key20180919073742_B70","first-page":"129","article-title":"Annex 3. Guidelines for the production of inactivated oral cholera vaccines","volume-title":"WHO Expert Committee on Biological Standardization: fifty-second report","year":"2004"},{"key":"key20180919073742_B71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0732-8893(83)90042-1","article-title":"Immunological differences among the cholera\/coli family of enterotoxins","volume":"1","author":"Marchlewicz","year":"1983","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"key20180919073742_B72","volume-title":"Dukoral product information","year":"2011"},{"key":"key20180919073742_B73","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1473-3099(07)70032-4","article-title":"Cholera vaccines","volume":"7","author":"Kabir","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"key20180919073742_B74","volume-title":"Position paper on cholera vaccine use in Iraq","year":"2007"},{"key":"key20180919073742_B75","volume-title":"Global alert and response, cholera in Zimbabwe","year":"2008"},{"key":"key20180919073742_B76","volume-title":"Dukoral product information","year":"2008"},{"key":"key20180919073742_B77","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0035-9203(95)90103-5","article-title":"Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians","volume":"89","author":"Sanchez","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"key20180919073742_B78","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1097\/00002030-199814000-00001","article-title":"Increase in plasma viral load after oral cholera immunization of HIV-infected subjects","volume":"12","author":"Ortig\u00e3o-de-Sampaio","year":"1998","journal-title":"AIDS"},{"key":"key20180919073742_B79","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/CVI.00562-10","article-title":"Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera","volume":"18","author":"Alam","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073742_B80","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/CVI.00196-12","article-title":"Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera","volume":"19","author":"Arifuzzaman","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073742_B81","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1128\/CVI.05615-11","article-title":"Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following cholera infection in Bangladesh","volume":"19","author":"Leung","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073742_B82","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1128\/CVI.00543-12","article-title":"Insights from natural infection-derived immunity to cholera instruct vaccine efforts","volume":"19","author":"Pasetti","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073742_B83","first-page":"187","article-title":"Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population\u2014the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae","volume":"40","author":"Mosley","year":"1969","journal-title":"Bull. World Health Organ."},{"key":"key20180919073742_B84","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/infdis\/125.6.672","article-title":"Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cell","volume":"125","author":"Northrup","year":"1972","journal-title":"J. Infect. Dis."},{"key":"key20180919073742_B85","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(06)70494-7","article-title":"Oral cholera vaccines: use in clinical practice","volume":"6","author":"Hill","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"key20180919073742_B86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.revmedmi.0000174307.33651.81","article-title":"Cholera vaccines: current status and problems","volume":"16","author":"Kabir","year":"2005","journal-title":"Rev. Med. Microbiol."},{"key":"key20180919073742_B87","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"key":"key20180919073742_B88","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/0264-410X(94)90176-7","article-title":"Immunological memory after immunization with oral cholera B subunit\u2014the whole-cell vaccine in Swedish volunteers","volume":"12","author":"Jertborn","year":"1994","journal-title":"Vaccine"},{"key":"key20180919073742_B89","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IDR.S10339","article-title":"Review of oral cholera vaccines: efficacy in young children","volume":"4","author":"Masuet Aumatell","year":"2011","journal-title":"Infect. Drug Resist."},{"key":"key20180919073742_B90","first-page":"117","article-title":"Cholera vaccines: WHO position paper","volume":"85","year":"2010","journal-title":"Wkly. Epidemiol. Rec."},{"key":"key20180919073742_B91","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.vaccine.2005.10.014","article-title":"A review of vaccine research and development: human enteric infections","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"key20180919073742_B92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4161\/hv.4.2.5122","article-title":"Cholera vaccines for the developing world","volume":"4","author":"Lopez","year":"2008","journal-title":"Hum. Vaccines"},{"key":"key20180919073742_B93","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0974-777X.77297","article-title":"Vaccination strategies to combat an infectious globe: oral cholera vaccines","volume":"3","author":"L\u00f3pez-Gigosos","year":"2011","journal-title":"J. Glob Infect. Dis."},{"key":"key20180919073742_B94","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1016\/j.vaccine.2013.06.096","article-title":"The state-of-the art of approved and under-development cholera vaccines","volume":"31","author":"Pastor","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073742_B95","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.vaccine.2012.11.012","article-title":"Immune responses and protection in children in developing countries induced by oral vaccines","volume":"31","author":"Qadri","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073742_B96","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"key":"key20180919073742_B97","volume-title":"Dukoral, det drickbara resevaccinet","year":"2005"},{"key":"key20180919073742_B98","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4269\/ajtmh.13-0370","article-title":"Hospitalizations and deaths caused by diarrhea in children five years old and younger at four hospitals in Haiti, 2010-2012","volume":"90","author":"Derby","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"key20180919073742_B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0035-9203(79)90119-6","article-title":"Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity","volume":"73","author":"Levine","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"key20180919073742_B100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/IAI.44.3.747-749.1984","article-title":"Neuraminidase production by Vibrio cholerae O1 and other diarrheagenic bacteria","volume":"44","author":"Kabir","year":"1984","journal-title":"Infect. Immun."},{"key":"key20180919073742_B101","first-page":"801","article-title":"Enzymes in Vibrio cholerae","volume":"52","author":"Shrivastava","year":"1964","journal-title":"Indian J. Med. Res."},{"key":"key20180919073742_B102","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1016\/j.vaccine.2004.02.012","article-title":"Characteristics of Vibrio cholerae proteinases: potential, candidate vaccine antigens","volume":"22","author":"Stewart-Tull","year":"2004","journal-title":"Vaccine"},{"key":"key20180919073742_B103","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.vaccine.2003.12.004","article-title":"Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase","volume":"22","author":"Stewart-Tull","year":"2004","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00378-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:38:35Z","timestamp":1746297515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00378-14"}},"subtitle":[],"editor":[{"given":"T. S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":103,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1128\/CVI.00378-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00378-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}